Company Filing History:

16 out of 613

Sankyo Company, Limited

where one patent can have more than one assignee

Years Active: 1976-1996

Loading Chart...

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 5489613 - Carbacyclin derivatives, process for their preparation and compositions (1996-02-06),

2. 5405870 - Carbacyclin compounds; pharmaceutical compositions and method of use (1995-04-11),

3. 4914093 - Pyridazinone derivatives, their preparation and use (1990-04-03),

4. 4757087 - Carbacyclin derivatives (1988-07-12),

5. 4464375 - 4-Anilinoquinazoline compounds and pharmaceutical compositions thereof (1984-08-07),

6. 4434179 - Wound-healing promoters (1984-02-28),

7. 4328238 - Benzothiazocine and benzothiazonine derivatives and use (1982-05-04),

8. 4322435 - Prostacyclin compounds (1982-03-30),

9. 4322420 - Method of using 4-anilinoquinazoline derivatives as analgesic and (1982-03-30),

10. 4260551 - Polyprenyl derivatives (1981-04-07),

11. 4199519 - Higher polyalkenyl fatty acids and esters (1980-04-22),

12. 4192953 - Polyprenyl derivatives (1980-03-11),

13. 4151357 - Polyprenyl piperazines (1979-04-24),

14. 4064351 - 9-OXO-15 .xi.-HYDROXY-20-ALKYLIDENEPROST-13(TRANS)-ENOIC ACID DERIVATIVES (1977-12-20),

15. 4059641 - Polyprenyl derivatives (1977-11-22),

Title: Shinsaku Kobayashi: Innovator in Pharmaceutical Chemistry

Introduction

Shinsaku Kobayashi is a prominent inventor based in Hiromachi, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds with valuable therapeutic properties. With a total of 16 patents to his name, Kobayashi's work has had a notable impact on medical science.

Latest Patents

Among his latest patents are innovative compounds known as Carbacyclin derivatives. These compounds exhibit valuable platelet-aggregation inhibitory activities, making them useful for the prophylaxis and treatment of diseases such as thrombosis. His patents also include pharmaceutical compositions and methods of use for these compounds, which further emphasize their potential in medical applications.

Career Highlights

Kobayashi has worked with notable companies in the pharmaceutical industry, including Sankyo Company, Limited and Ube Industries, Inc. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking research in drug development.

Collaborations

Throughout his career, Kobayashi has collaborated with esteemed colleagues such as Akira Ogiso and Koichi Kojima. These partnerships have fostered a collaborative environment that has led to significant advancements in their respective fields.

Conclusion

Shinsaku Kobayashi's contributions to pharmaceutical chemistry and his innovative patents highlight his role as a key figure in the industry. His work continues to influence the development of new treatments for critical health conditions.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com